Benitec Biopharma Correlations
BNTC Stock | USD 14.20 1.91 11.86% |
The current 90-days correlation between Benitec Biopharma and Zura Bio Limited is 0.39 (i.e., Weak diversification). The correlation of Benitec Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Benitec Biopharma Correlation With Market
Significant diversification
The correlation between Benitec Biopharma Ltd and DJI is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Benitec Biopharma Ltd and DJI in the same portfolio, assuming nothing else is changed.
Benitec |
Moving against Benitec Stock
0.63 | WMT | Walmart Aggressive Push | PairCorr |
0.59 | CMND | Clearmind Medicine Common | PairCorr |
0.55 | CDIOW | Cardio Diagnostics | PairCorr |
0.53 | OCEAW | Ocean Biomedical | PairCorr |
0.52 | ASMB | Assembly Biosciences Earnings Call This Week | PairCorr |
0.48 | MLSS | Milestone Scientific Earnings Call This Week | PairCorr |
0.44 | SCLX | Scilex Holding | PairCorr |
0.8 | HD | Home Depot | PairCorr |
0.73 | DIS | Walt Disney | PairCorr |
0.59 | JPM | JPMorgan Chase | PairCorr |
0.53 | CAT | Caterpillar | PairCorr |
0.52 | MSFT | Microsoft | PairCorr |
0.46 | BA | Boeing | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Benitec Stock performing well and Benitec Biopharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Benitec Biopharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
BPTH | 8.68 | (0.47) | 0.00 | (0.58) | 0.00 | 15.63 | 189.05 | |||
CBIO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
DFFN | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
CAPR | 3.94 | 0.18 | 0.03 | 0.06 | 4.77 | 8.41 | 22.77 | |||
NXTC | 3.52 | (0.75) | 0.00 | (0.48) | 0.00 | 6.49 | 21.57 | |||
EFTR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
LABP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
APGN | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
NAVB | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
ANGN | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Benitec Biopharma Corporate Management
Michael Graham | Founding Scientist and Head of Discovery | Profile | |
Bryan Dulhunty | Chief Officer | Profile | |
Sophie Mukadam | Chief Officer | Profile | |
Claudia Kloth | Senior Manufacturing | Profile | |
Craig Lewis | Chief Adviser | Profile |